PDGFRB and infantile myofibromatosis: The p.Arg561Cys mutation in familial infantile myofibromatosis is predicted in silico to decrease autoinhibition of PDGF-Rβ and lead to high PDGF-Rβ signaling activity, suggesting that a gain-of-function mechanism contributes to the pathogenesis of this condition39.